Every L-Theanine batch is verified by HPLC for purity, confirmed by optical rotation testing for L-isomer chiral purity, and tested for heavy metals and microbial safety. Full documentation with every shipment.
Every batch is tested by HPLC to confirm ≥98% L-Theanine content. Purity certificates issued per batch with full analytical chromatography data.
L-Theanine's specific optical rotation [α]D²⁵ = +6.0° to +8.0° is verified per batch — confirming the biologically active L-isomer and ruling out D-Theanine contamination.
Lead, mercury, arsenic, cadmium, and pesticide residues tested to USP and EU limits. Microbial safety (TPC, yeast/mould, E. coli, Salmonella) verified before export.
COA, MSDS, Certificate of Origin, and Phytosanitary Certificate prepared for every shipment. Halal/Kosher certificates available on request.
The caffeine and L-Theanine combination is the most clinically validated cognitive ingredient stack available to supplement formulators today — supported by over a dozen randomised controlled trials across diverse populations and cognitive tasks. Understanding the ratio between the two compounds is the key formulation decision: different caffeine-to-theanine ratios produce meaningfully different subjective and measurable cognitive effects, and matching the ratio to the product's positioning is essential for delivering the experience that users expect.
L-Theanine works by attenuating the glutamate receptor activation and sympathetic nervous system stimulation caused by caffeine — reducing jitteriness, blood pressure elevation, and post-caffeine crash — while preserving and enhancing caffeine's dopaminergic and adenosine-blocking mechanisms. The result is a smoothed, extended focus window rather than a sharp stimulant peak. The ratio below guides formula selection by use case.
The lightest modulation — preserves most of caffeine's energising effect while noticeably reducing jitteriness and anxiety in caffeine-sensitive users. Common in energy drinks with a "clean energy" positioning and mainstream pre-workout formulas where high stimulation is still desired.
The ratio used in the majority of peer-reviewed studies. Consistently outperforms caffeine alone on tasks measuring sustained attention, working memory accuracy, and task-switching speed. Reduces self-reported headaches, jitteriness, and heart rate elevation. This is the go-to ratio for nootropic stacks, productivity supplements, and focus formulas targeting knowledge workers and students.
At this ratio, L-Theanine's calming and alpha-wave effects dominate the formula. Caffeine contributes minimal stimulation; the primary effect is focused relaxation suitable for extended cognitive tasks, creative work, and users with high caffeine sensitivity. Popular in afternoon or evening focus products and mindfulness-adjacent supplement lines.
Without caffeine, L-Theanine at 200–400mg shows clinically significant improvements in sleep quality (increased slow-wave sleep duration), reduction in stress biomarkers (salivary chromogranin A), and reduced trait anxiety scores. The preferred form for children's calm supplements, sleep formulas, and products positioned as caffeine-free alternatives for the growing stimulant-free consumer segment.
The human brain operates across a spectrum of electrical oscillation frequencies, each associated with a distinct mental state. Beta waves (13–30 Hz) dominate during active thinking, anxiety, and alertness. Theta waves (4–8 Hz) characterise drowsy or meditative states. Gamma waves (>30 Hz) reflect intense cognitive processing. Alpha waves — sitting at 8–12 Hz — represent the neurological "sweet spot" of wakeful relaxation: calm, open awareness without the agitation of beta or the drowsiness of theta.
L-Theanine selectively amplifies alpha-wave oscillations within 30–60 minutes of oral ingestion. EEG studies consistently show significant increases in occipital and parietal alpha-band power after 50–200mg doses. The mechanism involves three simultaneous pathways: increased GABA synthesis (inhibiting neural overactivation), competitive partial agonism at NMDA glutamate receptors (reducing excitatory drive), and increased synthesis of dopamine and serotonin in the frontal cortex.
The result is the neural equivalent of the state experienced after sitting quietly for twenty minutes — without any of the time or effort investment. For supplement formulators, this means L-Theanine delivers a subjectively distinct, measurable experience that users can feel — a rare quality in the nootropic ingredient market and a strong driver of repeat purchase.